Please login to the form below

Not currently logged in
Email:
Password:

ProPharma selects new CEO and president

Dawn Sherman takes up the roles effective 14 May

ProPharma Group has appointed a new chief executive officer and president in the form of Dawn Sherman.

Sherman brings extensive international strategy and experience to the group following multiple executive leadership positions.

Most recently, Sherman was president of EnvisionRxOptions, a role where she was responsible for the pharmacy benefit management and technology company lines of business.

She has also held the role of chief operating officer for Teva Pharmaceuticals, where her focus included strategy and innovation for patient solutions, commercial effectiveness, market access, business insights and market intelligence.

Sherman said: “It is an honour to join ProPharma Group and the great people that have contributed to the company’s success.

“I am incredibly excited about the many opportunities that lie ahead for this dynamic, growing business.

Sherman succeeds Jeff Hargroves, founder and CEO of ProPharma group, who will continue to be an active member of the board.

1st May 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics